Clinical Trial Update: Levacor™ Ventricular Assist Device (VAD) Bridge to Transplant Study [NA]

View source ↗

Summary

The Levacor Ventricular Assist Device trial for bridge to transplant in patients with heart failure has been terminated. The sponsor is World Heart Corporation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Levacor Ventricular Assist Device

Snippet

Sponsor: World Heart Corporation | Conditions: Refractory Heart Failure | NA | Status: TERMINATED